| __timestamp | Alkermes plc | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 199905000 | 38783000000 |
| Thursday, January 1, 2015 | 311558000 | 42585000000 |
| Friday, January 1, 2016 | 374130000 | 45702000000 |
| Sunday, January 1, 2017 | 421578000 | 46372000000 |
| Monday, January 1, 2018 | 526408000 | 46910000000 |
| Tuesday, January 1, 2019 | 599449000 | 48890000000 |
| Wednesday, January 1, 2020 | 538827000 | 50129000000 |
| Friday, January 1, 2021 | 560977000 | 54559000000 |
| Saturday, January 1, 2022 | 605747000 | 62081000000 |
| Sunday, January 1, 2023 | 689751000 | 105931000000 |
| Monday, January 1, 2024 | 645238000 | 77201000000 |
Unveiling the hidden dimensions of data
In the competitive pharmaceutical landscape, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Dr. Reddy's Laboratories Limited and Alkermes plc, two prominent players, showcase contrasting strategies over the past decade. From 2014 to 2023, Dr. Reddy's consistently reported higher SG&A expenses, peaking at approximately $10.6 billion in 2023, a staggering 170% increase from 2014. In contrast, Alkermes plc's SG&A expenses grew by about 245% during the same period, reaching nearly $690 million in 2023. This disparity highlights Dr. Reddy's expansive operations and market reach, while Alkermes focuses on streamlined operations. Notably, 2024 data for Alkermes is missing, indicating potential reporting delays or strategic shifts. As the industry evolves, these companies' approaches to cost management will be pivotal in shaping their financial health and competitive edge.
Who Optimizes SG&A Costs Better? Novartis AG or Dr. Reddy's Laboratories Limited
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Alkermes plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Opthea Limited
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Halozyme Therapeutics, Inc.
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs CymaBay Therapeutics, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited and Geron Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Alkermes plc or Apellis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Alkermes plc and Amicus Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Alkermes plc or Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Alkermes plc vs Veracyte, Inc. Trends and Insights